Elehear Beyond Pro vs Otofonix Groove

The Elehear Beyond Pro is a mid-priced OTC hearing aid that earns an A grade with a SoundScore of 4.2/5 in our lab testing, placing it in the top 15% of the OTC category. Priced at $631, this behind-the-ear device has received HearAdvisor's Expert's Choice Award in both 2024 and 2025. In our testing, the Beyond Pro demonstrates notable strengths in music streaming, scoring 3.8/5—a solid result that sits 1.88 points above the category average. This makes it one of the stronger options for users who prioritize audio entertainment alongside speech clarity. Speech performance is also above average, with speech in quiet scoring 3.3/5 (+0.46 vs category) and speech in noise at 2.5/5 (+1.00 vs category). While the speech-in-noise score is above the category average, it remains mixed in absolute terms at 2.5/5. Feedback handling is excellent at 5.0/5. The primary trade-off is own-voice comfort, which scores 1.2/5—a low result that falls 1.31 points below the category average. Users who are sensitive to how their own voice sounds may find this noticeable. The Beyond Pro is best suited for OTC shoppers who want strong streaming quality and solid speech performance without professional fitting. It competes in a price range that includes higher-scoring options like the Yeasound RIC800 and Sony CRE-E10, so prospective buyers may want to compare based on their priorities. Features include rechargeable batteries, iPhone and Android streaming, and hands-free capability.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.